CD5 and synovial sarcoma: Another study found no significant difference in the percentage of CD5+ B cells compared to that observed in healthy controls; however, IL-21 receptor and Granzyme B expression in CD5+ B cells in primary SS patients were markedly enhanced, indicating the elicitation of an increased counter-regulatory reaction (145).